Please wait while the formulary information is being retrieved.
REGRANEX (BECAPLERMIN)
- Diabetic neuropathic ulcer of lower extremity
0.01 % topical gel
- Apply the calculated amount of gel to the affected area(s) by topicalroute once daily
Diabetic neuropathic ulcer of lower extremity
- Apply the calculated amount of gel to the affected area(s) by topicalroute once daily
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- Malignancy
Severe
Moderate
- None
REGRANEX (BECAPLERMIN)
- Diabetic neuropathic ulcer of lower extremity
- None
- None
More Frequent
Severe
Less Severe
- None
- Erythema
- Skin rash
- Stinging of skin
- Treatment site sequelae
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Malignancy
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Becaplermin
No safety and efficacy age < 16 years.
- 1 Day – 16 Years
- No safety and efficacy age < 16 years.
Becaplermin
- Severity Level:
2
- Additional Notes: Insufficient human data available.
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
Becaplermin
Insufficient data available.
General | Excretion Potential | Effect on Infant | Notes |
Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available. |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Diabetic neuropathic ulcer of lower extremity | |
E08.621 | Diabetes mellitus due to underlying condition with foot ulcer |
E09.621 | Drug or chemical induced diabetes mellitus with foot ulcer |
E10.621 | Type 1 diabetes mellitus with foot ulcer |
E11.621 | Type 2 diabetes mellitus with foot ulcer |
E13.621 | Other specified diabetes mellitus with foot ulcer |
0-9 | A-Z |
---|---|
E08.621 | Diabetes mellitus due to underlying condition with foot ulcer |
E09.621 | Drug or chemical induced diabetes mellitus with foot ulcer |
E10.621 | Type 1 diabetes mellitus with foot ulcer |
E11.621 | Type 2 diabetes mellitus with foot ulcer |
E13.621 | Other specified diabetes mellitus with foot ulcer |
Formulary Reference Tool